Connect with us on LinkedIn
Save the Date for PharmaLink 2014: March 18-21, 2014

 Why Attend PharmaLink?

Inspiring Collaboration…

  • Feel the Purpose-Driven nature of this conference as soon as you enter the room.
  • Expect orchestrated engagement with your peers across the industry on topics you are passionate about.
  • Work side-by-side with regulators to deepen the understanding on both sides of challenges and opportunities.

Leading Innovation…

  • Identify solutions that will protect your patients around the world, your company brand, and your business.
  • Learn what you didn’t know you didn’t know! Other industries successfully demonstrate what pharma lacks. Walk away with real solutions.

Making a Difference…

  • Work through real working models that can improve the reliability of your product….today.
  • Leave the conference armed with action plans that are orchestrated throughout the conference and solidified before you leave

 

 Testimonials for PharmaLink 2013

“The PharmaLink conference is by all accounts a highly successful International Event.”

-Paul Teitell, FDA District Director, Cincinnati

* * *

“The PharmaLink meeting was well-organised and interesting. You treated us so well. I discussed the presentations with Anne and we decided to organize an internal meeting in Fimea to discuss the impact of the potential problems of the global supply chain on various functions in the agency. Thus, the meeting may have an impact also in Finland!”

-Pekka Kurki, MD. Head of Section, Department of Marketing Authorization, National Agency for Medicines Finland (Fimea)

* * *

“This is a great event and I was very happy to attend and take part. Very informative and has inspired me to push through some new projects.”

-Dan Bell, Vice President, Regulatory Compliance and Technical Affairs, Marken

* * *

“I found the PharmaLink conference a really valuable few days. I appreciate how hard the management team must have worked to put together an event which ran so smoothly, and which maintained a clear purpose throughout the agenda items.”

-David Churchward, Expert GMP Inspector, MHRA

* * *

“Very topical, thought provoking & thoroughly engaging!”

-PharmaLink 2013 attendee

2013 PharmaLink
Conference Deliverables

  1. View our Video Gallery

  2. View our Session Summaries

  3. Xavier PharmaLink in the News: Gold Sheet: After Issuing 40 Drug GMP Warning Letters in FY 2012, FDA Aims to Improve Drug Quality This Year

  4. Review our 2013 Conference Presentations
  5. Review 20122011 and 2010 Conference Presentations and 2012 Session Recaps
  6. Listen to former FDA Steve Niedelman discuss the Impact of FDASIA

Podcast: How will FDASIA impact FDA Inspections?

Listen to a section of the recent FDASIA webinar, as Kathleen Culver (Field Investigator and Drug Pre-Approval Manager, FDA, Cincinnati District) discuss the impact of FDASIA on FDA Inspections:

 

Podcast: How will FDASIA impact FDA Inspections?

Listen to a section of the recent FDASIA webinar, as Kathleen Culver (Field Investigator and Drug Pre-Approval Manager, FDA, Cincinnati District) discuss the impact of FDASIA on FDA Inspections:

2013 Demographics

  • 138 participants
  • 47 Companies
  • 21 States
  • 4 Countries
  • 15 FDA Representatives

Areas of Attendee Expertise:

  • 35% Quality
  • 26% Supply Chain
  • 26% Regulatory
  • 8% Operations
  • 5% Other

Thank You to Our 2013 Sponsors!!

 
 
Food and Drug Administration Xavier University